These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 33193327)
1. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative. Karin N Front Immunol; 2020; 11():557586. PubMed ID: 33193327 [TBL] [Abstract][Full Text] [Related]
2. The role of CCR5 in directing the mobilization and biological function of CD11b Karin N; Razon H Cancer Immunol Immunother; 2018 Dec; 67(12):1949-1953. PubMed ID: 30232521 [TBL] [Abstract][Full Text] [Related]
3. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially. Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236 [TBL] [Abstract][Full Text] [Related]
4. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production. Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386 [TBL] [Abstract][Full Text] [Related]
5. Plasticity of myeloid-derived suppressor cells in cancer. Tcyganov E; Mastio J; Chen E; Gabrilovich DI Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768 [TBL] [Abstract][Full Text] [Related]
6. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor. Zilio S; Bicciato S; Weed D; Serafini P J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35064009 [TBL] [Abstract][Full Text] [Related]
7. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
8. CCR5 Directs the Mobilization of CD11b Hawila E; Razon H; Wildbaum G; Blattner C; Sapir Y; Shaked Y; Umansky V; Karin N Cell Rep; 2017 Nov; 21(8):2212-2222. PubMed ID: 29166611 [TBL] [Abstract][Full Text] [Related]
9. In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells. Singh A; Rieber N Methods Mol Biol; 2021; 2236():77-83. PubMed ID: 33237542 [TBL] [Abstract][Full Text] [Related]
10. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. Weber R; Riester Z; Hüser L; Sticht C; Siebenmorgen A; Groth C; Hu X; Altevogt P; Utikal JS; Umansky V J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788238 [TBL] [Abstract][Full Text] [Related]
11. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator. Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744 [TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α. Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249 [No Abstract] [Full Text] [Related]
13. On the origin of myeloid-derived suppressor cells. Millrud CR; Bergenfelz C; Leandersson K Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients. Bruderek K; Schirrmann R; Brandau S Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535 [TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624 [TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets. Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893 [No Abstract] [Full Text] [Related]
18. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential. Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells. Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569 [TBL] [Abstract][Full Text] [Related]